Kern Winfried V, Steib-Bauert Michaela, Fellhauer Matthias, Baumann Jürgen, Först Gesche, Kramme Evelyn, Dörje Frank, de With Katja
Universitätsklinikum Freiburg, Klinik für Innere Medizin II, Abteilung Infektiologie, Freiburg i.Br., GERMANY.
Medizinische Fakultät, Universität Freiburg.
Dtsch Med Wochenschr. 2025 Jan;150(3):e1-e10. doi: 10.1055/a-2445-3397. Epub 2024 Nov 29.
An important prerequisite for ascertaining rational antibiotic prescribing is the availability and evaluation of antibiotic use data. In this study we report evolving trends of antibiotic use in German hospitals during the last decade.Using drug dispensing data from acute care hospital pharmacies, we calculated yearly antibiotic use density values for the period from 2012/13 through to 2021/22. Use density was expressed as daily doses per 100 patient days, using both hospital adapted doses of antibiotics ("", RDD) as well as WHO-"" (DDD). The 2021/22 data were extrapolated to estimate the hospital consumption in DDD per 1000 population and day.The overall antibiotic use density remained stable during the observation period. It was 41.9 RDD/100 patient days (median, n=169 hospitals, interquartile range 35-48 RDD/100) in the year 2012/13 and 42.1 RDD/100 (median, n=329, interquartile range 35-48 RDD/100) in the year 2021/22, respectively. The estimated national use per population in 2021/22 was 1.85 DDD per 1000 inhabitants and day. The antibiotic use levels in university hospitals (54.0 RDD/100) were higher than in non-university hospitals that showed a similar use density across different hospital size categories (medians between 39.8 and 44.0 RDD/100). Overall, penicillin use increased over time (change in proportion +63%), while fluoroquinolones (- 54%) and first and second generation cephalosporins (- 41%) were prescribed less frequently. Antibiotic use density in intensive care units was approximately twice as high as in normal wards. High levels of antibiotic use were also observed in haematology-oncology divisions at teaching hospitals (median 96.8 RDD/100), in urology (medians between 65.1 and 70.5 RDD/100) and oto-rhino-laryngology (medians between 49.1 and 60.9 RDD/100) and urology divisions.During the last decade, there was no increasing use of antibiotics in German acute care hospitals. We observed shifts in selected drug classes, in particular an increasing use of penicillins. The estimated hospital antibiotic consumption per population was slightly above the European average.
确定合理使用抗生素的一个重要前提是抗生素使用数据的可得性和评估。在本研究中,我们报告了德国医院过去十年抗生素使用的演变趋势。利用急性护理医院药房的药品配发数据,我们计算了2012/13年至2021/22年期间的年度抗生素使用密度值。使用密度以每100个患者日的每日剂量表示,同时使用医院调整后的抗生素剂量(“,RDD)以及世界卫生组织的”(DDD)。对2021/22年的数据进行了外推,以估计每1000人口每日的DDD医院消耗量。在观察期内,总体抗生素使用密度保持稳定。2012/13年为41.9 RDD/100患者日(中位数,n = 169家医院,四分位间距35 - 48 RDD/100),2021/22年为42.1 RDD/100(中位数,n = 329,四分位间距35 - 48 RDD/100)。2021/22年估计的全国人均使用量为每1000居民每日1.85 DDD。大学医院的抗生素使用水平(54.0 RDD/100)高于非大学医院,非大学医院在不同规模类别中显示出相似的使用密度(中位数在39.8至44.0 RDD/100之间)。总体而言,青霉素的使用随时间增加(比例变化 +63%),而氟喹诺酮类药物(-54%)以及第一代和第二代头孢菌素(-41%)的处方频率降低。重症监护病房的抗生素使用密度约为普通病房的两倍。在教学医院的血液肿瘤科室(中位数96.8 RDD/100)、泌尿外科(中位数在65.1至70.5 RDD/100之间)和耳鼻喉科(中位数在49.1至60.9 RDD/100之间)以及泌尿外科也观察到高抗生素使用水平。在过去十年中,德国急性护理医院的抗生素使用没有增加。我们观察到某些药物类别发生了变化,特别是青霉素的使用增加。估计的人均医院抗生素消耗量略高于欧洲平均水平。